top of page


FDA Approves Leucovorin for Rare Genetic Disorder but Declines Use for Autism Treatment
Recently, FDA or the U.S. Food and Drug Administration has accepted the medicine Leucovorin for curing of genetic disease linked to folate metabolism. This approval gives new hope for patients who struggle with serious neurological and developmental signs due to the circumstance. However, the FDA declined to approve leucovorin as a remedy for Autism Spectrum Disorder. Regulators stated modern-day scientific proof does now not really prove that the drug is secure and powerful
-
18 minutes ago2 min read
bottom of page
